🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04971187
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The primary objective of the study is to assess the safety and tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00839007
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of Bendamu...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-04-23
Trial ID
NCT00916058
Treatments Being Tested
Part A of this study evaluates iopofosine I 131 (CLR 131) in patients with ...
Status
Active Not Recruiting
Location
Cellectar Biosciences site
Start Date
2017-07-26
Trial ID
NCT02952508
Treatments Being Tested
The primary objective of the study is to evaluate efficacy of entospletinib...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-03-14
Trial ID
NCT01799889
Treatments Being Tested
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024